Detalhe da pesquisa
1.
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial.
Lancet Oncol
; 25(3): 376-387, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38309282
2.
Comparative analysis of tabelecleucel and current treatment in patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease following hematopoietic cell transplant or solid organ transplant.
J Med Econ
; 27(1): 789-795, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38727527
3.
Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy.
Bone Marrow Transplant
; 59(1): 52-58, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37865719
4.
Oral white patches in a national sample of medical HIV patients in the era of HAART.
Community Dent Oral Epidemiol
; 33(2): 99-106, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15725172
5.
Self-reported satisfaction of enrollees in capitated and fee-for-service dental benefit plans.
J Am Dent Assoc
; 135(10): 1458-66; quiz 1469, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15551989
6.
Self-reported oral health of enrollees in capitated and fee-for-service dental benefit plans.
J Am Dent Assoc
; 135(11): 1606-15, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15622667
7.
Experience of Advate rAHF-PFM in previously untreated patients and minimally treated patients with haemophilia A.
Thromb Haemost
; 107(6): 1072-82, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22476554
8.
Characteristics of malt liquor beer drinkers in a low-income, racial minority community sample.
Alcohol Clin Exp Res
; 29(3): 402-9, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15770116
9.
A longitudinal analysis of unmet need for oral treatment in a national sample of medical HIV patients.
Am J Public Health
; 95(1): 73-5, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15623862